BVF INC/IL - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 81 filers reported holding SPERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,859,000
+68.6%
1,929,376
-37.6%
0.16%
+43.2%
Q2 2022$2,289,000
-83.4%
3,089,615
+94.9%
0.11%
-79.9%
Q1 2022$13,795,000
-45.7%
1,585,6150.0%0.55%
-40.1%
Q4 2021$25,386,000
-23.8%
1,585,615
-12.4%
0.92%
-29.2%
Q3 2021$33,310,000
+11.6%
1,809,352
-15.4%
1.30%
+16.2%
Q2 2021$29,846,000
-5.2%
2,137,9780.0%1.12%
-5.2%
Q1 2021$31,471,000
-27.6%
2,137,978
-4.7%
1.18%
-31.0%
Q4 2020$43,497,000
+189.9%
2,243,278
+66.9%
1.71%
+109.4%
Q3 2020$15,003,000
+127.9%
1,344,334
+176.3%
0.82%
+101.2%
Q2 2020$6,583,000
+44.6%
486,540
-13.6%
0.41%
-4.2%
Q1 2020$4,552,000
-44.0%
563,393
-33.4%
0.42%
-31.2%
Q4 2019$8,129,000
-18.4%
845,405
-10.0%
0.62%
-41.2%
Q3 2019$9,961,000
-7.9%
939,7040.0%1.05%
-11.3%
Q2 2019$10,816,000
+83.3%
939,704
+104.0%
1.18%
+78.7%
Q1 2019$5,902,000
+13.8%
460,706
-45.4%
0.66%
-2.5%
Q4 2018$5,185,000
-66.8%
843,146
-43.3%
0.68%
-50.7%
Q3 2018$15,640,000
+1.6%
1,488,088
+41.9%
1.37%
-8.5%
Q2 2018$15,388,000
+2.9%
1,048,9580.0%1.50%
-0.9%
Q1 2018$14,948,000
+23.6%
1,048,958
+1.9%
1.52%
+3.9%
Q4 2017$12,093,0001,029,1851.46%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders